Cite

HARVARD Citation

    Windschall, D. et al. (2016). Safety and efficacy of etanercept and adalimumab in children aged 2 to 4 years with juvenile idiopathic arthritis. Clinical rheumatology. 35 (12), pp. 2925-2931. [Online]. 
  
Back to record